Prednisone therapy in pediatric epilepsy

被引:67
|
作者
Sinclair, DB [1 ]
机构
[1] Univ Alberta, Walter MacKenzie Hlth Sci Ctr, Div Pediat Neurol, Comprehens Epilepsy Program, Edmonton, AB T6G 2B7, Canada
关键词
D O I
10.1016/S0887-8994(02)00513-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Steroids are often an effective treatment for the West's syndrome. There have been few reports of steroid use in children with epilepsy outside the first year of life. I report my experience with prednisone for the treatment of older children with intractable epilepsy. Twenty-eight children (17 boys, 11 girls) aged 18 months to 10 years with intractable epilepsy were studied. Prednisone 1 mg/kg/day for 12 weeks (6 weeks daily and 6 weeks alternate therapy) was prescribed in addition to their regular antiepileptic medications. The parents kept seizure diaries, and the patients were regularly assessed for seizure frequency and side effects. The follow-up period was for 1 to 5 years. Thirteen patients (46%) became seizure free on prednisone and another 18 (40%) had a significant decrease in seizure frequency. Five patients (19%) had no change in seizure frequency. The best outcomes were seen in the absence group in which six out of seven patients became seizure free and in the Lennox-Gastaut syndrome group in which seven out of 10 became seizure free. Side effects were uncommon and included weight gain in five patients and aggression in four patients. Prednisone therapy is a safe and effective adjunctive treatment for epilepsy. It should be considered as an alternative treatment for older children with intractable generalized epilepsy who have failed conventional antiepileptic therapy. (C) 2003 by Elsevier Inc. All rights reserved.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [31] Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: A retrospective analysis
    Neveu, Julien
    Villeneuve, Nathalie
    Milh, Mathieu
    Desnous, Beatrice
    EPILEPSY RESEARCH, 2021, 177
  • [32] CYCLOSPORIN-A AND PREDNISONE VERSUS PREDNISONE IN THE THERAPY OF THE ENDOCRINE OPHTHALMOPATHY
    KAHALY, G
    SCHREZENMEIR, J
    SCHWEIKERT, B
    KRAUSE, U
    BEYER, J
    ACTA ENDOCRINOLOGICA, 1985, 109 : 17 - 17
  • [33] PREDNISONE THERAPY FOR CLUSTER HEADACHE
    COUCH, JR
    ZIEGLER, DK
    HEADACHE, 1978, 18 (04): : 219 - 221
  • [34] PREDNISONE THERAPY IN BRONCHOPULMONARY DYSPLASIA
    KAGAN, JM
    GOETZMAN, BW
    PEDIATRIC RESEARCH, 1975, 9 (04) : 397 - 397
  • [35] PREDNISONE THERAPY OF THE HIRSUTE FEMALE
    BETESH, JS
    BIRNBAUM, MD
    ROSE, LI
    CLINICAL RESEARCH, 1981, 29 (05): : A820 - A820
  • [36] RESULTS OF PREDNISONE THERAPY IN HIRSUTISM
    BETESH, JS
    BIRNBAUM, MD
    ROSE, LI
    CLINICAL RESEARCH, 1982, 30 (03): : A684 - A684
  • [37] HYPERLIPOPROTEINEMIA ASSOCIATED WITH PREDNISONE THERAPY
    KOLTERMAN, OG
    FRIES, JF
    MCDEVITT, HO
    STERN, M
    REAVEN, GM
    ARTHRITIS AND RHEUMATISM, 1971, 14 (03): : 396 - +
  • [38] PREDNISONE THERAPY AND ULCER HEALING
    KLEIN, M
    GUTIERREZ, D
    MARKINSON, B
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1988, 78 (07): : 370 - 372
  • [39] ECCHYMOSES FOLLOWING PREDNISONE THERAPY
    STEFANINI, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 164 (12): : 1383 - 1383
  • [40] ORAL PREDNISONE - AN ILLOGICAL THERAPY
    ARNOLD, HL
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1987, 26 (05) : 286 - 288